Encyclopedia  |   World Factbook  |   World Flags  |   Reference Tables  |   List of Lists     
   Academic Disciplines  |   Historical Timeline  |   Themed Timelines  |   Biographies  |   How-Tos     
Sponsor by The Tattoo Collection
Pulmonary embolism
Main Page | See live article | Alphabetical index

Pulmonary embolism

A pulmonary embolism occurs when a blood clot, generally a venous thrombus, becomes dislodged from its site of formation and embolizes to the arterial blood supply of one of the lungs, causing vascular obstruction and impaired gas exchange.

Table of contents
1 Signs and symptoms
2 Causes
3 Diagnosis
4 Further analysis
5 Treatment
6 Prognosis

Signs and symptoms

Signs of PE are (sudden) shortness of breath (dyspnea), rapid breathing rate (tachypnea), pleuritic chest pain, cough, hemoptysis (coughing up blood), and in severe cases, hypotension, loss of consciousness, and death.

Causes

The most common sources of embolism are pelvic vein thromboses or proximal leg deep venous thromboses (DVTs).

Generally PE's are caused by a synergism of several predisposing factors, roughly to be divided into genetic, acquired and circumstantial causes:

Diagnosis

The diagnosis of pulmonary embolism (PE), suspected on the basis of shortness of breath and chest pain, with or without an abnormal x-ray, can be confirmed by a medical test called a "ventilation-perfusion scan" (or V/Q scan), which shows that some areas of the lung are being ventilated but not perfused with blood (due to obstruction by a clot).

Recent research has shown that in low suspicion of PE, a blood test (D dimer) might be enough to exclude the possibility of PE as cause of someone's symptoms.

Instead of the V/Q scan spiral computed tomography (spiral CT) is increasingly being used, especially when other lung disorders are part of the differential diagnosis.

Further analysis

When a PE is being suspected, a number of blood tests are also done, in order to exclude important secondary causes of PE. This includes a full blood count, clotting status (PT, APTT, TT), and some screening tests (Erythrocyte sedimentation rate, renal function, liver enzymes, electrolytes). If one of these is abnormal, further investigations might be warranted.

Treatment

Treatment is via infusion of thrombolytic drugs (only in submassive PE) and anticoagulation (heparin or low-molecular weight heparin, later warfarin or coumadins - generally for 6 months).

Prognosis

Prognosis depends on the amount of lung that is affected and on the co-existence of other debilitating conditions. Chronic embolisation to the lung can lead to pulmonary hypertension.

After a first PE, the search for secondary causes is usually brief. Only when a second PE occurs, and especially when this happens while still under anticoagulant therapy, a further search for underlying conditions is undertaken. This will include testing (see above for full list) for Factor V Leiden mutation, antiphospholipid antibodies, protein C and S and antithrombin levels, and later prothrombin mutation, MTHFR mutation, Factor VIII concentration and rarer inherited coagulation abnormalities.


Health science - Medicine - Hematology
Hematological malignancy and White blood cells
Lymphoma (Hodgkin's disease;, NHL) - Leukemia (ALL, AML, CLL, CML) - Multiple myeloma; - MDS - Myelofibrosis - Myeloproliferative disease; (Thrombocytosis, Polycythemia) - Neutropenia
Red blood cells
Anemia - Hemochromatosis - Sickle-cell anemia; - Thalassemia - other hemoglobinopathies
Coagulation and Platelets
Thrombosis - Deep venous thrombosis; - Pulmonary embolism; - Hemophilia - ITP - TTP